Curis Lifesciences (NSE:CURIS) Total Operating Expense: ₹76.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
19 GF Score
Price ₹112.00
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences Total Operating Expense?

Curis Lifesciences NSE:CURIS +1.82% 19 Total Operating Expense is ₹76.8 Mil as of Mar. 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Curis Lifesciences's Total Operating Expense for the six months ended in Mar. 2026 was ₹76.8 Mil. Curis Lifesciences's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹76.8 Mil.

Curis Lifesciences Total Operating Expense Related Terms

Curis Lifesciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences Total Operating Expense Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Total Operating Expense
45.78 42.22 64.90 76.75

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Total Operating Expense 45.78 42.22 64.90 76.75
NSE:CURIS
19GF Score
Curis Lifesciences Ltd NSE:CURIS
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹76.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹76.8 Mil mean?
Curis Lifesciences (NSE:CURIS) has a Total Operating Expense of ₹76.8 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Curis Lifesciences and its competitors.
Is Curis Lifesciences' Total Operating Expense too high?
Curis Lifesciences' current Total Operating Expense is ₹76.8 Mil. Overall, Curis Lifesciences has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Total Operating Expense compare to ZTS?
Curis Lifesciences' Total Operating Expense of ₹76.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Curis Lifesciences and its competitors. Curis Lifesciences's current Total Operating Expense is ₹76.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Total Operating Expense of ₹76.8 Mil. The current Total Operating Expense is ₹76.8 Mil. Curis Lifesciences' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Total Operating Expense is ₹76.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
19GF Score

Get the complete analysis for NSE:CURIS

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹112.00
Price